• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

OPEN LETTER: INCREASING THE EARLY DIAGNOSIS OF LUNG CANCER IN EUROPE: AN ESSENTIAL MILESTONE TO TACKLE THE BIGGEST CANCER KILLER

Dear MEPs, The European Respiratory Society (ERS), together with the undersigned 27 organisations, urges you to take into account the […]

IASCL LANGUAGE GUIDE

The International Association for the Study of Lung Cancer released its first-ever Language Guide to promote best practices in all […]

LUCE WEBINAR: STRENGHTENING THE LUNG CANCER PATIENT VOICE IN HEALTH POLICY AND REGULATORY DECISION

As part of its Educational & Capacity Building Programme, Lung Cancer Europe (LuCE) ran an introductory session on Strengthening the Lung Cancer Patient Voice […]

INVESTING IN THE FUTURE: IMPROVING CANCER BIOMARKER TESTING AND CANCER DIAGNOSIS FOR SUSTAINABLE HEALTHCARE

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by […]

LIVING WITH LUNG CANCER: SURVIVORSHIP AND QUALITY OF LIFE – SURVEY FOR PATIENTS AND CAREGIVERS

Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such […]

LUCE WEBINAR: CURRENT RESEARCH LINES IN LUNG CANCER

Lung Cancer Europe (LuCE) held a webinar on current research lines in lung cancer. The webinar was given by Professor Simon […]